BCAL Diagnostics Limited (ASX:BDX)
Australia
· Delayed Price · Currency is AUD 0.0870
+0.0030 (3.57%)
Apr 28, 2025, 4:10 PM AEST
BCAL Diagnostics Market Cap
BCAL Diagnostics has a market cap or net worth of 30.74 million as of April 28, 2025. Its market cap has increased by 38.46% in one year.
Market Cap
30.74M
Enterprise Value
25.03M
Revenue
2.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since July 21, 2021, BCAL Diagnostics's market cap has decreased from 51.72M to 30.74M, a decrease of -40.56%. That is a compound annual growth rate of -12.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 30.74M | -13.40% |
| Dec 31, 2024 | 35.50M | 42.50% |
| Dec 29, 2023 | 24.91M | 96.37% |
| Dec 29, 2022 | 12.69M | -50.95% |
| Dec 29, 2021 | 25.87M | -49.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 117.13B |
| Pro Medicus | 22.02B |
| Cochlear | 17.31B |
| Sonic Healthcare | 12.25B |
| Telix Pharmaceuticals | 9.65B |
| Ramsay Health Care | 7.63B |
| Ansell | 4.26B |
| Mesoblast | 2.29B |